FR2999937B1 - Unite solide a haute teneur en fexofenadine et son procede de preparation - Google Patents

Unite solide a haute teneur en fexofenadine et son procede de preparation

Info

Publication number
FR2999937B1
FR2999937B1 FR1262647A FR1262647A FR2999937B1 FR 2999937 B1 FR2999937 B1 FR 2999937B1 FR 1262647 A FR1262647 A FR 1262647A FR 1262647 A FR1262647 A FR 1262647A FR 2999937 B1 FR2999937 B1 FR 2999937B1
Authority
FR
France
Prior art keywords
fexofenadine
preparing
same
solid unit
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1262647A
Other languages
English (en)
Other versions
FR2999937A1 (fr
Inventor
Jean-Yves Lanne
Baptiste Merillon
Marie Renouard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47902228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2999937(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR1262647A priority Critical patent/FR2999937B1/fr
Priority to ARP130104869A priority patent/AR094146A1/es
Priority to CN201380073493.5A priority patent/CN105073101B/zh
Priority to AU2013366512A priority patent/AU2013366512B2/en
Priority to PCT/EP2013/077752 priority patent/WO2014096387A1/fr
Priority to PL13814955T priority patent/PL2934491T3/pl
Priority to CA2895607A priority patent/CA2895607A1/fr
Priority to EP13814955.4A priority patent/EP2934491B1/fr
Priority to KR1020157018523A priority patent/KR20150100725A/ko
Priority to SG11201504394TA priority patent/SG11201504394TA/en
Priority to ES13814955.4T priority patent/ES2625447T3/es
Priority to US14/651,621 priority patent/US9757340B2/en
Priority to BR112015014137A priority patent/BR112015014137B8/pt
Priority to JP2015548645A priority patent/JP6276287B2/ja
Priority to TW102147630A priority patent/TWI624275B/zh
Priority to UY0001035235A priority patent/UY35235A/es
Priority to HUE13814955A priority patent/HUE032393T2/en
Priority to MX2015008068A priority patent/MX360047B/es
Priority to EA201591150A priority patent/EA030982B1/ru
Publication of FR2999937A1 publication Critical patent/FR2999937A1/fr
Publication of FR2999937B1 publication Critical patent/FR2999937B1/fr
Application granted granted Critical
Priority to ZA2015/04079A priority patent/ZA201504079B/en
Priority to IL239267A priority patent/IL239267A0/en
Priority to TNP2015000267A priority patent/TN2015000267A1/fr
Priority to CL2015001681A priority patent/CL2015001681A1/es
Priority to PH12015501377A priority patent/PH12015501377A1/en
Priority to HK15112148.9A priority patent/HK1211234A1/xx
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1262647A 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation Expired - Fee Related FR2999937B1 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR1262647A FR2999937B1 (fr) 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation
ARP130104869A AR094146A1 (es) 2012-12-21 2013-12-19 Unidad solida con alto contenido en fexofenadina y su procedimiento de preparacion
TW102147630A TWI624275B (zh) 2012-12-21 2013-12-20 具有高含量菲索芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）之固態單位及其製備方法
UY0001035235A UY35235A (es) 2012-12-21 2013-12-20 Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.
PCT/EP2013/077752 WO2014096387A1 (fr) 2012-12-21 2013-12-20 Unité solide avec teneur élevée en fexofénadine et procédé de préparation de celle-ci
PL13814955T PL2934491T3 (pl) 2012-12-21 2013-12-20 Stała jednostka o wysokiej zawartości feksofenadyny i sposób jej wytwarzania
CA2895607A CA2895607A1 (fr) 2012-12-21 2013-12-20 Unite solide avec teneur elevee en fexofenadine et procede de preparation de celle-ci
EP13814955.4A EP2934491B1 (fr) 2012-12-21 2013-12-20 Unité solide avec teneur élevée en fexofénadine et procédé de préparation de celle-ci
KR1020157018523A KR20150100725A (ko) 2012-12-21 2013-12-20 높은 펙소페나딘 함량을 갖는 고형 단위 및 이의 제조 방법
SG11201504394TA SG11201504394TA (en) 2012-12-21 2013-12-20 Solid unit with high fexofenadine content and process for the preparation thereof
ES13814955.4T ES2625447T3 (es) 2012-12-21 2013-12-20 Unidad sólida con alto contenido de fexofenadina y proceso para la preparación de la misma
US14/651,621 US9757340B2 (en) 2012-12-21 2013-12-20 Solid unit with high fexofenadine content and process for the preparation thereof
BR112015014137A BR112015014137B8 (pt) 2012-12-21 2013-12-20 Composição com alto teor de fexofenadina e processo para a preparação da mesma
JP2015548645A JP6276287B2 (ja) 2012-12-21 2013-12-20 フェキソフェナジン高含有固形単位およびその製造法
CN201380073493.5A CN105073101B (zh) 2012-12-21 2013-12-20 具有高含量非索非那定的固体单元及其制备方法
AU2013366512A AU2013366512B2 (en) 2012-12-21 2013-12-20 Solid unit with high fexofenadine content and process for the preparation thereof
HUE13814955A HUE032393T2 (en) 2012-12-21 2013-12-20 For the preparation of a solid dosage unit and process having a high fexofenadine content
MX2015008068A MX360047B (es) 2012-12-21 2013-12-20 Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.
EA201591150A EA030982B1 (ru) 2012-12-21 2013-12-20 Твердая галеновая форма с высоким содержанием фексофенадина и способ ее получения
ZA2015/04079A ZA201504079B (en) 2012-12-21 2015-06-05 Solid unit with high fexofenadine content and process for the preparation thereof
IL239267A IL239267A0 (en) 2012-12-21 2015-06-07 A solid unit with fexofenadine and a process for its manufacture
TNP2015000267A TN2015000267A1 (en) 2012-12-21 2015-06-10 Solid unit with high fexofenadine content and process for the preparation thereof
CL2015001681A CL2015001681A1 (es) 2012-12-21 2015-06-16 Unidad solida con alto contenido en fexofenadina; procedimiento de preparacion; y uso de la misma como antihistaminico, broncodilatador y/o para el tratamiento de alergias y/o urticarias.
PH12015501377A PH12015501377A1 (en) 2012-12-21 2015-06-17 Solid unit with high fexofenadine content and process for the preparation thereof
HK15112148.9A HK1211234A1 (en) 2012-12-21 2015-12-09 Solid unit with high fexofenadine content and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1262647A FR2999937B1 (fr) 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation

Publications (2)

Publication Number Publication Date
FR2999937A1 FR2999937A1 (fr) 2014-06-27
FR2999937B1 true FR2999937B1 (fr) 2015-01-09

Family

ID=47902228

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1262647A Expired - Fee Related FR2999937B1 (fr) 2012-12-21 2012-12-21 Unite solide a haute teneur en fexofenadine et son procede de preparation

Country Status (25)

Country Link
US (1) US9757340B2 (fr)
EP (1) EP2934491B1 (fr)
JP (1) JP6276287B2 (fr)
KR (1) KR20150100725A (fr)
CN (1) CN105073101B (fr)
AR (1) AR094146A1 (fr)
AU (1) AU2013366512B2 (fr)
BR (1) BR112015014137B8 (fr)
CA (1) CA2895607A1 (fr)
CL (1) CL2015001681A1 (fr)
EA (1) EA030982B1 (fr)
ES (1) ES2625447T3 (fr)
FR (1) FR2999937B1 (fr)
HK (1) HK1211234A1 (fr)
HU (1) HUE032393T2 (fr)
IL (1) IL239267A0 (fr)
MX (1) MX360047B (fr)
PH (1) PH12015501377A1 (fr)
PL (1) PL2934491T3 (fr)
SG (1) SG11201504394TA (fr)
TN (1) TN2015000267A1 (fr)
TW (1) TWI624275B (fr)
UY (1) UY35235A (fr)
WO (1) WO2014096387A1 (fr)
ZA (1) ZA201504079B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2956011B1 (fr) 2013-02-14 2018-03-28 Sanofi Composition à mâcher pour administration orale et son procédé de préparation
WO2017073738A1 (fr) * 2015-10-29 2017-05-04 日本臓器製薬株式会社 Comprimé ayant comme principe actif la fexofénadine
KR20220123689A (ko) 2020-03-11 2022-09-08 사와이세이야쿠 가부시키가이샤 과립 및 그것을 이용한 제제
WO2023145871A1 (fr) * 2022-01-31 2023-08-03 住友精化株式会社 Procédé de fabrication de composition pour préparation pharmaceutique, et procédé de fabrication de préparation pharmaceutique
WO2023145869A1 (fr) * 2022-01-31 2023-08-03 住友精化株式会社 Procédé de fabrication de composition pour préparation pharmaceutique, et procédé de fabrication de préparation pharmaceutique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044319C (zh) * 1984-08-30 1999-07-28 默里尔多药物公司 热熔融抗组胺组合物的制备方法
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
DE69624559T2 (de) 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
EP1454635B1 (fr) * 2003-03-07 2007-12-19 Ind-Swift Limited Complexes insipides, directement compressibles ,à dissolution rapide et leurs formulations pharmaceutiques
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
EP2956011B1 (fr) 2013-02-14 2018-03-28 Sanofi Composition à mâcher pour administration orale et son procédé de préparation

Also Published As

Publication number Publication date
HK1211234A1 (en) 2016-05-20
CN105073101B (zh) 2018-10-09
JP2016511223A (ja) 2016-04-14
AU2013366512A1 (en) 2015-07-09
ZA201504079B (en) 2016-04-28
UY35235A (es) 2014-07-31
IL239267A0 (en) 2015-07-30
EP2934491B1 (fr) 2017-02-22
TN2015000267A1 (en) 2016-10-03
EA030982B1 (ru) 2018-10-31
SG11201504394TA (en) 2015-07-30
TW201431569A (zh) 2014-08-16
BR112015014137A2 (pt) 2017-07-11
CA2895607A1 (fr) 2014-06-26
PH12015501377A1 (en) 2015-09-02
CL2015001681A1 (es) 2015-08-21
PL2934491T3 (pl) 2017-09-29
BR112015014137B1 (pt) 2022-12-13
ES2625447T3 (es) 2017-07-19
FR2999937A1 (fr) 2014-06-27
MX360047B (es) 2018-10-19
AR094146A1 (es) 2015-07-15
WO2014096387A1 (fr) 2014-06-26
KR20150100725A (ko) 2015-09-02
HUE032393T2 (en) 2017-09-28
JP6276287B2 (ja) 2018-02-07
CN105073101A (zh) 2015-11-18
TWI624275B (zh) 2018-05-21
BR112015014137B8 (pt) 2023-01-24
MX2015008068A (es) 2016-04-25
EA201591150A1 (ru) 2015-11-30
AU2013366512B2 (en) 2017-11-09
US9757340B2 (en) 2017-09-12
EP2934491A1 (fr) 2015-10-28
US20150313885A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
SG11201502756PA (en) Stable long-term method for producing c5-aldehydes
ZA201501833B (en) Method for obtaining 1-kestone
EP2906697A4 (fr) Procédés permettant de surveiller l'expression de c9orf72
SG11201503362QA (en) Method for the production of oxazolidinone compounds
EP2857377A4 (fr) Procédé de fabrication de 1,4-butanediol
EP2913831A4 (fr) Procédé de production d'un aimant en terre rare
EP2826766A4 (fr) Procédé de production de 2,3,3,3-tétrafluoropropène
BR112015008077A2 (pt) métodos para a produção de um produto de fermentação
GB201222693D0 (en) Novel method
EP2831249A4 (fr) Procédé de fermentation
EP2837619A4 (fr) Procédé de production de beta -alcoxypropionamide
EP2873730A4 (fr) Procédé de fabrication biologique d'acide cis-5-hydroxy-l-pipécolique
SG11201403205SA (en) Process for making levulinic acid
FR2977585B1 (fr) Procede de preparation d'esters
FR2999937B1 (fr) Unite solide a haute teneur en fexofenadine et son procede de preparation
EP2824130A4 (fr) Procédé de production de polydialkylsilane
HK1204607A1 (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2- methyl-pentanoic acid compounds 4--5--4--2--2--
EP2899270A4 (fr) Procédé de fabrication de butanediol
EP2840088A4 (fr) Procédé de préparation d'acide 5,6,4'-trihydroxyflavone-7-0-d-glucuronique
EP2871033A4 (fr) Procédé de production pour béton
IL235959A0 (en) A method for obtaining a nano-capsule structure
PL2929769T3 (pl) Sposób zwiększania wydajności plonów
EP2860520A4 (fr) Procédé de diagnostic de matériau
EP2878202A4 (fr) Procédé de fabrication d'une pâte pour pâtisseries danoises
EP2855433A4 (fr) Procédé de préparation de dihalopyridines

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20200914